Lista de obras -

A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

article

A collagen-fibrin patch for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: A randomized clinical trial

artículo científico publicado en 2018

A systematic variant screening in familial cases of congenital heart defects demonstrates the usefulness of molecular genetics in this field.

artículo científico publicado en 2015

ABCA transporter gene expression and poor outcome in epithelial ovarian cancer

artículo científico publicado en 2014

ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas

scientific article published on August 2013

ASO Author Reflections: Systematic Lymph Node Dissection in Ovarian Cancer Under Attack

scientific article published on 12 November 2018

Abdominal wall metastases in patients with ovarian cancer after laparoscopic surgery: incidence, risk factors, and complications.

artículo científico publicado en 2010

Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients

artículo científico publicado en 2014

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

artículo científico

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

artículo científico publicado en 2018

Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

artículo científico publicado en 2017

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

artículo científico publicado en 2013

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

artículo científico publicado en 2016

BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study.

artículo científico publicado en 2016

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

artículo científico publicado en 2015

Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival ⬇️

artículo científico publicado el 8 de noviembre de 2010

Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

artículo científico publicado en 2015

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

artículo científico publicado en 2015

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

artículo científico publicado en 2015

Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

artículo científico publicado en 2015

Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk

artículo científico publicado en 2014

Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers

artículo científico publicado en 2020

Current and future options in the management and treatment of uterine sarcoma

artículo científico publicado en 2014

Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions

artículo científico publicado en 2018

Differences in the receptor status between primary and recurrent breast cancer--the frequency of and the reasons for discordance

artículo científico publicado en 2013

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12

artículo científico publicado en 2018

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma

artículo científico publicado en 2020

Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

artículo científico publicado en 2017

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

artículo científico publicado en 2013

Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

artículo científico publicado en 2015

Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study

artículo científico publicado en 2014

Fertility-sparing surgery in ovarian cancer: a systematic review.

artículo científico publicado en 2013

French national survey on infective endocarditis and the Melody™ valve in percutaneous pulmonary valve implantation

artículo científico publicado en 2018

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

artículo científico publicado en 2016

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

artículo científico publicado en 2013

Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk

artículo científico publicado en 2018

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

artículo científico publicado en 2016

Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

artículo científico publicado en 2015

Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.

artículo científico publicado en 2013

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer

artículo científico publicado en 2016

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

artículo científico publicado en 2013

Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer

publication published on 23 June 2021

Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

artículo científico publicado en 2015

Impact of Abdominal Wall Metastases on Prognosis in Epithelial Ovarian Cancer.

artículo científico publicado en 2016

Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer.

artículo científico

Implementation of robot-assisted gynecologic surgery for patients with low and high BMI in a German gynecological cancer center.

artículo científico publicado en 2014

In reply: response to Sammartino et al

artículo científico publicado en 2013

Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

artículo científico publicado en 2016

Intake of selective beta blockers has no impact on survival in patients with epithelial ovarian cancer.

artículo científico publicado en 2016

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome

artículo científico publicado en 2014

Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study

artículo científico publicado en 2015

Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery

scientific article published on 21 June 2019

Low-grade Serous Ovarian Carcinoma

artículo científico publicado en 2018

Management of borderline ovarian tumors

artículo científico publicado en 2016

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?

artículo científico publicado en 2012

Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

artículo científico publicado en 2015

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

artículo científico publicado en 2016

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

artículo científico publicado en 2015

Operative and Conservative Treatment of Uterine Sarcomas

artículo científico publicado en 2014

Outcome of early breast cancer treated in an urban and a rural breast cancer unit in Germany.

artículo científico publicado en 2013

Outcome of immediate re-operation or interval debulking after chemotherapy at a gynecologic oncology center after initially incomplete cytoreduction of advanced ovarian cancer

artículo científico publicado en 2012

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

artículo científico publicado en 2016

Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer

scientific article published on 18 November 2018

Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery.

artículo científico publicado en 2016

Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study.

artículo científico publicado en 2017

Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery

artículo científico publicado en 2015

Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer.

artículo científico publicado en 2015

Prognostic Impact of Port-Site Metastasis After Diagnostic Laparoscopy for Epithelial Ovarian Cancer.

artículo científico publicado en 2016

Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian Cancer

artículo científico publicado en 2017

Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer

scientific article published on 23 January 2014

Prognostic factors for complete debulking in first- and second-line ovarian cancer.

artículo científico publicado en 2009

Prognostic impact of additional extended surgical procedures in advanced-stage primary ovarian cancer

artículo científico publicado en 2009

Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV.

artículo científico publicado en 2015

Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer

artículo científico publicado en 2014

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

scientific article published on 23 September 2019

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study

artículo científico publicado en 2017

Requirements to assess feasibility of phase 0 trials during major abdominal surgery: variability of PARP activity

artículo científico publicado en 2012

Response to the letter of Fagotti et al. regarding the manuscript: "Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery".

artículo científico publicado en 2016

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10

artículo científico publicado en 2013

Role of cytoreductive surgery in recurrent ovarian cancer.

artículo científico publicado en 2009

Serous Tubal Intraepithelial Carcinoma Associated With Extraovarian Metastases.

artículo científico publicado en 2017

Shared heritability and functional enrichment across six solid cancers

artículo científico publicado en 2019

Shared heritability and functional enrichment across six solid cancers

Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery

artículo científico publicado en 2018

Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic Lymphadenectomy

artículo científico publicado en 2018

Staging laparoscopy for the management of early-stage ovarian cancer: a metaanalysis

artículo científico publicado en 2013

Surgery for recurrent ovarian cancer

artículo científico publicado en 2011

Surgery for relapsed ovarian cancer: when should it be offered?

artículo científico publicado en 2012

Surgical intervention in relapsed ovarian cancer is beneficial: pro.

artículo científico publicado en 2013

Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer

Synchronous ovarian and endometrial cancer--an international multicenter case-control study.

artículo científico publicado en 2014

Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer

article

Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs.

artículo científico publicado en 2010

The genetic landscape of 87 ovarian germ cell tumors

scientific article published on 28 August 2018

The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery

artículo científico publicado en 2017

The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?

artículo científico publicado en 2016

The sandwich technique of diaphragmatic stripping or full-thickness resection for advanced ovarian cancer: how to keep it short and simple

artículo científico publicado en 2015

Treatment of recurrent ovarian cancer

scientific article published on 01 November 2017

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.

artículo científico publicado en 2009

Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study

artículo científico publicado en 2018

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

artículo científico publicado en 2018

Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer

artículo científico publicado en 2014

When should Surgery be used for Recurrent Ovarian Carcinoma?

artículo científico publicado en 2018

rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

artículo científico publicado en 2018

Lista de obras de

A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

A collagen-fibrin patch for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: A randomized clinical trial

A systematic variant screening in familial cases of congenital heart defects demonstrates the usefulness of molecular genetics in this field.

ABCA transporter gene expression and poor outcome in epithelial ovarian cancer

ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas

ASO Author Reflections: Systematic Lymph Node Dissection in Ovarian Cancer Under Attack

Abdominal wall metastases in patients with ovarian cancer after laparoscopic surgery: incidence, risk factors, and complications.

Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival ⬇️

Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk

Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers

Current and future options in the management and treatment of uterine sarcoma

Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions

Differences in the receptor status between primary and recurrent breast cancer--the frequency of and the reasons for discordance

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma

Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study

Fertility-sparing surgery in ovarian cancer: a systematic review.

French national survey on infective endocarditis and the Melody™ valve in percutaneous pulmonary valve implantation

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer

Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Impact of Abdominal Wall Metastases on Prognosis in Epithelial Ovarian Cancer.

Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer.

Implementation of robot-assisted gynecologic surgery for patients with low and high BMI in a German gynecological cancer center.

In reply: response to Sammartino et al

Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

Intake of selective beta blockers has no impact on survival in patients with epithelial ovarian cancer.

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome

Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study

Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery

Low-grade Serous Ovarian Carcinoma

Management of borderline ovarian tumors

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?

Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Operative and Conservative Treatment of Uterine Sarcomas

Outcome of early breast cancer treated in an urban and a rural breast cancer unit in Germany.

Outcome of immediate re-operation or interval debulking after chemotherapy at a gynecologic oncology center after initially incomplete cytoreduction of advanced ovarian cancer

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer

Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery.

Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study.

Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery

Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer.

Prognostic Impact of Port-Site Metastasis After Diagnostic Laparoscopy for Epithelial Ovarian Cancer.

Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian Cancer

Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer

Prognostic factors for complete debulking in first- and second-line ovarian cancer.

Prognostic impact of additional extended surgical procedures in advanced-stage primary ovarian cancer

Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV.

Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study

Requirements to assess feasibility of phase 0 trials during major abdominal surgery: variability of PARP activity